Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigens

Adoptive T-cell transfer (ACT) offers a curative therapeutic option for subsets of melanoma and hematological cancer patients. To increase response rates and broaden the applicability of ACT, it is necessary to improve the post-infusion performance of the transferred T cells. The design of improved...

Descripción completa

Detalles Bibliográficos
Autores principales: Jæhger, Ditte E., Hübbe, Mie L., Kræmer, Martin K., Clergeaud, Gael, Olsen, André V., Stavnsbjerg, Camilla, Wiinholt, Mette N., Kjær, Andreas, Henriksen, Jonas R., Hansen, Anders E., Andresen, Thomas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492729/
https://www.ncbi.nlm.nih.gov/pubmed/34611284
http://dx.doi.org/10.1038/s41598-021-99347-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492729/
https://www.ncbi.nlm.nih.gov/pubmed/34611284
http://dx.doi.org/10.1038/s41598-021-99347-0

Ejemplares similares